BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26920997)

  • 21. Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy.
    Oliveira RD; Fontana V; Junta CM; Marques MM; Macedo C; Rassi DM; Passos GA; Donadi EA; Louzada-Junior P
    J Rheumatol; 2012 Aug; 39(8):1524-32. PubMed ID: 22753658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis.
    Nakazawa F; Matsuno H; Yudoh K; Katayama R; Sawai T; Uzuki M; Kimura T
    J Rheumatol; 2001 Aug; 28(8):1800-8. PubMed ID: 11508582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis.
    Cribbs AP; Kennedy A; Penn H; Amjadi P; Green P; Read JE; Brennan F; Gregory B; Williams RO
    Arthritis Rheumatol; 2015 May; 67(5):1182-92. PubMed ID: 25604080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients.
    van der Heijden JW; Assaraf YG; Gerards AH; Oerlemans R; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
    Scand J Rheumatol; 2014; 43(1):9-16. PubMed ID: 23987246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of T lymphocytes and synovial macrophages from rheumatoid arthritis patients.
    Cutolo M; Capellino S; Montagna P; Sulli A; Seriolo B; Villaggio B
    Ann Rheum Dis; 2006 Jun; 65(6):728-35. PubMed ID: 16269423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synoviocyte apoptosis may differentiate responder and non-responder patients to methotrexate treatment in rheumatoid arthritis.
    Lee SY; Park SH; Lee SW; Lee SH; Son MK; Choi YH; Chung WT; Yoo YH
    Arch Pharm Res; 2014 Oct; 37(10):1286-94. PubMed ID: 24988987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
    Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
    Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro effects of methotrexate on polyamine levels in lymphocytes from rheumatoid arthritis patients.
    Nesher G; Osborn TG; Moore TL
    Clin Exp Rheumatol; 1996; 14(4):395-9. PubMed ID: 8871838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis.
    Cutolo M; Bisso A; Sulli A; Felli L; Briata M; Pizzorni C; Villaggio B
    J Rheumatol; 2000 Nov; 27(11):2551-7. PubMed ID: 11093433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
    Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
    Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis.
    Derambure C; Dzangue-Tchoupou G; Berard C; Vergne N; Hiron M; D'Agostino MA; Musette P; Vittecoq O; Lequerré T
    Arthritis Res Ther; 2017 May; 19(1):109. PubMed ID: 28545499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Methotrexate Complexes Endowed with New Biological Properties Envisioned for Musculoskeletal Regeneration in Rheumatoid Arthritis Environments.
    Fernández-Villa D; Ramírez-Jiménez RA; Aranaz I; Acosta N; Vázquez-Lasa B; Rojo L
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folate receptor-mediated targeted therapy for rheumatoid arthritis by methotrexate-phospholipid complex nano-emulsions.
    Li C; Luo X; Qian C; Huang J; Yi X; Su H; Han Y
    J Drug Target; 2023 Apr; 31(4):402-410. PubMed ID: 36724823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate: a gold standard for treatment of rheumatoid arthritis.
    Shinde CG; Venkatesh MP; Kumar TM; Shivakumar HG
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):351-8. PubMed ID: 25322199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mannose-mediated nanodelivery of methotrexate to macrophages augments rheumatoid arthritis therapy.
    Yang L; Sha Y; Wei Y; Fang H; Jiang J; Yin L; Zhong Z; Meng F
    Biomater Sci; 2023 Mar; 11(6):2211-2220. PubMed ID: 36748266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation specific environment activated methotrexate-loaded nanomedicine to treat rheumatoid arthritis by immune environment reconstruction.
    Tian J; Chen T; Huang B; Liu Y; Wang C; Cui Z; Xu H; Li Q; Zhang W; Liang Q
    Acta Biomater; 2023 Feb; 157():367-380. PubMed ID: 36513249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment.
    Wijngaarden S; van Roon JA; van de Winkel JG; Bijlsma JW; Lafeber FP
    Rheumatology (Oxford); 2005 Jun; 44(6):729-34. PubMed ID: 15757966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients.
    Takatori R; Takahashi KA; Tokunaga D; Hojo T; Fujioka M; Asano T; Hirata T; Kawahito Y; Satomi Y; Nishino H; Tanaka T; Hirota Y; Kubo T
    Clin Exp Rheumatol; 2006; 24(5):546-54. PubMed ID: 17181924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressive influences of methotrexate on the generation of CD14(+) monocyte-lineage cells from bone marrow of patients with rheumatoid arthritis.
    Hirohata S; Yanagida T; Hashimoto H; Tomita T; Ochi T
    Clin Immunol; 1999 Apr; 91(1):84-9. PubMed ID: 10219258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of methotrexate (MTX) on expression of signalling lymphocytic activation molecule (SLAM) in patients with rheumatoid arthritis (RA) and its role in the regulation of cytokine production.
    Morita Y; Fukazawa T; Hirashima M; Kaga K; Kusaoi M; Morita T; Touyama S; Morita K; Takasaki Y; Hashimoto H
    Scand J Rheumatol; 2006; 35(4):268-72. PubMed ID: 16882589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.